stock-mb-logo-androidstock-mb-logo-ios
Stock Screener App
Free - Play StoreApp Store
InstallInstall
logo
Tscan Therapeutics IncTCRX
$0.14273.84%-0.0057

Tscan Therapeutics Inc (TCRX)

Tscan Therapeutics Inc stock is traded at $0.1427, with a volume of 319,792. It is down -3.84% in the last 24 hours and down -32.11% over the past month. TScan Therapeutics Inc is a fully integrated clinical-stage biotechnology company focused on developing a robust pipeline of T cell receptor (TCR)-engineered T cell, or TCR-T, therapies for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.
Previous Close:
$0.1484
Open:
$0.1526
24h Volume:
319,792
Relative Volume:
0.72
Market Cap:
$9.67M
Revenue:
$9.14M
Net Income/Loss:
-$124.31M
P/E Ratio:
-
EPS:
-$0.9573
Net Cash Flow:
-$125.43M
1W Performance:
-15.06%
1M Performance:
-32.11%
6M Performance:
-85.18%
1Y Performance:
-86.15%
1-Day Range:
$0.14$0.157
1-Week Range:
$0.14$0.1678
52-Week Range:
$0.14$1.47

Tscan Therapeutics Inc Stock (TCRX) Company Profile

Name
Tscan Therapeutics Inc
Phone
857-399-9500
Address
830 WINTER STREET, WALTHAM, USA
Employee
142
X
-
Next Earnings Date
-
Latest SEC Filings
SEC
TCRX's Discussions on X
X

 

Market Cap

 

Revenue

 

Net Income

 

Cash Flow

 

EPS

 

Tscan Therapeutics Inc Stock (TCRX) Financials Data

Similar to TCRX